Manifestations of Addison's disease in the dental office
Keywords:
Manifestations of Addison's disease, Dentistry, early detection, Clinical Diagnosis, findingsAbstract
Introduction: It is imperative to foster interdisciplinary collaboration among dentists, endocrinologists, and primary care physicians to ensure a comprehensive approach to the diagnosis and management of this condition.
Objective: To examine the existing scientific evidence regarding various aspects of Addison's disease in the dental office.
Material and methods: A literature review was conducted in 2024, with a 15-year selection period; the search was limited to Spanish and English languages. It yielded 40 publications from a total of 78 publications found. The initial search was conducted in three databases: PubMed, Scielo, and Scopus. The search was performed using the following formula: "Early manifestations of Addison's disease" in "Addison's disease in the dental office."
Results: Modern treatment of Addison's disease focuses on developing new glucocorticoid administration regimens that reduce associated morbidity and mortality. Recent research is focused on optimizing these therapies to improve long-term patient outcomes.
Conclusions: Early detection and appropriate management of oral manifestations and other related complications are essential to improve the quality of life and prognosis of these patients.
Downloads
References
1. Husebye ES, Pearce SH, Krone NP, Kämpe O. Adrenal insufficiency. Lancet [Internet]. 2021 [Citado 2/03/2024];397:613-29. Disponible en: https://doi.org/10.1016/S0140-6736(21)00136-7
2. Pearce SH, Gan EH, Napier C. Management of endocrine disease: residual adrenal function in Addison's disease. European Journal of Endocrinology. 2021; 184(2): R61-R67.
3. Thawabteh AM, Jibreen A, Karaman D, Thawabteh A, Karaman R. Skin Pigmentation Types, Causes and Treatment-A Review. Molecules [Internet]. 2023 [Citado 2/03/2024];28(12). Disponible en: https://www.mdpi.com/1420-3049/28/12/4839
4. Mohamed F, Raal FJ. Hyperpigmentation from Addison’s disease. N Engl J Med. 2021;384:1752.
5. Freitas PFS, Oliveira JM, Kater CE. Crisis? What crisis? Abdominal pain and darkening skin in Addison’s disease. Lancet [Internet]. 2020 [Citado 2/03/2024];396:498. Disponible en: https://doi.org/10.1016/S0140-6736(20)31680-9
6. Laugesen K, Jørgensen JOL, Petersen I, Sørensen HT. Fifteen-year nationwide trends in systemic glucocorticoid drug use in Denmark. European Journal of Endocrinology [Internet]. 2019 [Citado 2/03/2024]; 181(3): 267-73. Disponible en: https://pubmed.ncbi.nlm.nih.gov/31269470/
7. Ahmet A, Gupta A, Malcolm J, Constantacos C. Approach to the patient: preventing adrenal crisis through patient and clinician education. The Journal of Clinical Endocrinology & Metabolism. 2023;108(7): 1797-805.
8. Saverino S, Falorni A. Autoimmune Addison's disease. Best Practice & Research Clinical Endocrinology & Metabolism[Internet]. 2020.[Citado 2/03/2024]; 34(1), 101379. Disponible: https://www.sciencedirect.com/science/article/abs/pii/S1521690X20300063
9. Choudhury S, Meeran K. Glucocorticoid replacement in Addison disease. Nat Rev Endocrinol. 2018 Sep;14(9):562.
10. Bachmeier CAE, Malabu U. Rare case of meningococcal sepsis-induced testicular failure, primary hypothyroidism and hypoadrenalism: Is there a link?. BMJ Case Rep [Internet]. 2018 [Citado 02/03/2024]; 2018:bcr2018224437. Disponible en: https://casereports.bmj.com/content/2018/bcr-2018-224437.short
11. Mayo J, Collazos J, Martínez E, Ibarra S. Adrenal function in the human immunodeficiency virus-infected patient. Arch Intern Med. 2002 May 27;162(10):1095-8.
12. Hasenmajer V, Bonaventura I, Minnetti M, Sada V, Sbardella E, Isidori AM. Non-Canonical Effects of ACTH: Insights Into Adrenal Insufficiency. Front Endocrinol [Internet]. 2021 [Citado 2/03/2024];12:701263. Disponible en: https://doi.org/10.3389/fendo.2021.701263
13. Bugălă NM, Carsote M, Stoica LE, Albulescu DM, Tuculina MJ, Preda SA, et al. New Approach to Addison Disease: Oral Manifestations Due to Endocrine Dysfunction and Comorbidties’ Burden. Diagnostics [Internet]. 2022 [Citado 2/03/2024];12:2080. Disponible en: https://doi.org/10.3390/diagnostics12092080
14. Hirota Y, Matsushita T. Hyperpigmentation as a clue to Addison disease. Cleve Clin J Med [Internet]. 2022 [Citado 2/03/2024];89(9). Disponible en: https://doi.org/10.3949/ccjm.89a.21082
15. Nowotny H, Ahmed SF, Bensing S, Beun JG, Brösamle M, Chifu I, et al. Therapy options for adrenal insufficiency and recommendations for the management of adrenal crisis. Endocrine [Internet]. 2021 [Citado 2/03/2024]; 71: 586-94. Disponible en: https://link.springer.com/article/10.1007/s12020-021-02649-6
16. Nowroozzadeh MH, Thornton S, Watson A, Syed ZA, Razeghinejad R. Ocular manifestations of endocrine disorders. Clinical and Experimental Optometry [Internet]. 2022 [Citado 2/03/2024]; 105(2): 105-16. Disponible en: https://www.tandfonline.com/doi/abs/10.1080/08164622.2021.1986354
17. López NAS, Vega JLS, Salazar JEC, Mariño AVC. Caracterización de pacientes con insuficiencia suprarrenal primaria en un hospital de tercer nivel de atención en Ecuador: un estudio transversal. Mediciencias UTA [Internet]. 2024 [Citado 2/03/2024]; 8(4):140-8. Disponible en: https://revistas.uta.edu.ec/erevista/index.php/medi/article/view/2634
18. Salazar CBV, Arboleda GCD, San Miguel CSQ, Rodríguez EMQ, Diaz NMR, Farfán FGG, et al. El papel de las pruebas de estimulación de cortisol en el diagnóstico de la insuficiencia suprarrenal. Brazilian Journal of Implantology and Health Sciences [Internet]. 2024 [Citado 2/03/2024]; 6(4): 952-63. Disponible en: https://bjihs.emnuvens.com.br/bjihs/article/view/1898
19. Hahner S, Ross RJ, Arlt W, Bancos I, Burger-Stritt S, Torpy DJ, et al. Adrenal insufficiency. Nat Rev Dis Primers. 2021;7:19.
20. Wina Dharmesti NW, Saraswati MR, Suastika K, Gotera W, Dwipayana IMP. Challenging Diagnosis of Addison's Disease Presenting with Adrenal Crisis. Case Rep Endocrinol [Internet]. 2021 [Citado 2/03/2024];7137950. Disponible en: https://doi.org/10.1155/2021/7137950
21. Bugălă NM, Carsote M, Stoica LE, Albulescu DM, Tuculina MJ, Preda SA, et al. New Approach to Addison Disease: Oral Manifestations Due to Endocrine Dysfunction and Comorbidties’ Burden. Diagnostics [Internet]. 2022 [Citado 2/03/2024];12:2080. Disponible en: https://doi.org/10.3390/diagnostics12092080
22. Herman JP. The neuroendocrinology of stress: Glucocorticoid signaling mechanisms. Psychoneuroendocrinology [Internet]. 2022 [Citado 2/03/2024];137: 105641. Disponible en: https://www.sciencedirect.com/science/article/abs/pii/S0306453021005151
23. Simpson H, Tomlinson J, Wass J, Dean J, Arlt W. Guidance for the prevention and emergency management of adult patients with adrenal insufficiency. Clinical Medicine [Internet]. 2020 [Citado 2/03/2024]; 20(4): 371-8. Disponible en: https://www.sciencedirect.com/science/article/pii/S1470211824035176
24. White K, Arlt W. Adrenal crisis in treated Addison’s disease: a predictable but under-managed event. Eur J Endocrinol. 2010 Jan;162(1):115-20.
25. Kumar R, Wassif WS. Adrenal insufficiency. Journal of Clinical Pathology. 2022; 75(7): 435-42.
26. Garrahy A, Thompson CJ. Hyponatremia and glucocorticoid deficiency. Front Horm Res. 2019;52:80-92.
27. Benner BJ, Alsma J, Feelders RA. Hyponatraemia and hyperpigmentation in primary adrenal insufficiency. BMJ Case Rep. 2019;12.
28. Barthel A, Benker G, Berens K, Diederich S, Manfras B, Gruber M, et al. An update on Addison’s disease. Exp Clin Endocrinol Diabetes [Internet]. 2019 [Citado 2/03/2024];127:165-75. Disponible en: https://www.thieme-connect.com/products/ejournals/html/10.1055/a-0804-2715
29. Chacón AGM, Wang C, Waqar D, Syeda SA, Kumar R, Meghana DR. Long-term usage of oral glucocorticoids leading to adrenal insufficiency: A comprehensive review of the literature. Cureus. 2023; 15(5).
30. Isidori AM, Arnaldi G, Boscaro M, Falorni A, Giordano C, Giordano R. Towards the tailoring of glucocorticoid replacement in adrenal insufficiency: the Italian Society of Endocrinology Expert Opinion. Journal of Endocrinological Investigation [Internet]. 2020 [Citado 2/03/2024]; 43:683-96. Disponible en: https://link.springer.com/article/10.1007/s40618-019-01146-y
31. Sandru F, Petrova E, Petrov B, Draghici A, Ghemigian A, Carsote M, et al. Not just weight loss. Ro J Med Pract. [Internet]. 2021 [Citado 2/03/2024];16:529-32. Disponible en: https://doi.org/10.37897/RMJ.2021.4.24
32. Jang W, Sohn Y, Park JH, Pai H, Kim DS, Kim B. Clinical characteristics of patients with adrenal insufficiency and fever. Journal of Korean Medical Science [Internet]. 2021 [Citado 2/03/2024]; 36(23). Disponible en: https://jkms.org/DOIx.php?id=10.3346/jkms.2021.36.e152
33. Anesi GL, Kerlin MP. The impact of resource limitations on care delivery and outcomes: routine variation, the coronavirus disease 2019 pandemic, and persistent shortage. Curr Opin Crit Care. 2021;27(5):513-9.
34. Mofokeng TRP, Beshyah SA, Ross IL. Characteristics and Challenges of Primary Adrenal Insufficiency in Africa: A Review of the Literature. Int J Endocrinol [Internet]. 2022 [Citado 2/03/2024]; 8907864. Disponible en: https://doi.org/10.1155/2022/8907864
35. Mofokeng TRP, Beshyah SA, Mahomed F, Ndlovu KCZ, Ross IL. Significant barriers to diagnosis and management of adrenal insufficiency in Africa. Endocr Connect. 2020;9(5):445-56.
36. Carsote M, Nistor C. Addison’s Disease: Diagnosis and Management Strategies. Int J Gen Med [Internet]. 2023 [Citado 2/03/2024];16:2187-210. Disponible en: https://doi.org/10.2147/IJGM.S390793
37. Le BT, Duong CM, Nguyen TQ, Nguyen CM. Two siblings with non-classic P450scc deficiency resulted from a novel mutation in CYP11A1 gene misdiagnosed as familial glucocorticoid deficiency. BMJ Case Rep [Internet]. 2022 [Citado 2/03/2024];15(12). Disponible en: https://doi.org/10.1136/bcr-2022-250238
38. Gaw G, Wemyss C, Goodall C. Steroid cover. British Dental Journal. 2021;231(10): 604.
39. Morar A, Ghemigian A, Tupea C, Petrova E, Popescu M. Twist of endocrine scenario: Approach of ectopic Cushing syndrome (review). Rom J Med Pract [Internet]. 2020 [Citado 2/03/2024];15:405-9. Disponible en: https://rjmp.com.ro/articles/2020.4/RJMP_2020_4_Art-07.pdf
40. Lee SC, Baranowski ES, Sakremath R, Saraff, V, Mohamed Z. Hypoglycaemia in adrenal insufficiency. Frontiers in Endocrinology [Internet]. 2023 [Citado 2/03/2024];14: 1198519. Disponible en: https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2023.1198519/full
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Revista Habanera de Ciencias Médicas
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All the content of this magazine is in Open Access, distributed according to the terms of the Creative Commons Attribution-Noncommercial 4.0 License that allows non-commercial use, distribution and reproduction without restrictions in any medium, provided that the primary source is duly cited.
Download PDF
